Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 23155-889

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 23155-889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120mg-100 (120mg 100)

Label for Lurasidone Hydrochloride Tablets 120 mg by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label indicates 30 film-coated tablets in a prescription dispensed package. It contains usage instructions for pharmacists and warnings, including a caution to keep out of reach of children.*

FDA Label Image

120mg (120mg)

Label for Lurasidone Hydrochloride Tablets 120 mg showing batch number, manufacturing and package dates as placeholders, quantity of 10 kg, approximately 20,000 tablets, and NDC number 23155-891-18. Instructions for storage in tight containers at 20° to 25°C with permitted excursions are included. The label states Rx only and is manufactured by Avet Pharmaceuticals Labs Inc., East Brunswick, NJ.*

FDA Label Image

20mg-90 (20mg 90)

Lurasidone Hydrochloride Tablets 20 mg film-coated oral tablets packaging label from Avet Pharmaceuticals Inc. The label indicates a bottle containing 90 tablets, prescription only, with storage instructions to keep the container tightly closed and at room temperature. It includes a barcode and directions to dispense medication guides at avetpharma.com.*

FDA Label Image

20mg (20mg)

Lurasidone Hydrochloride Tablets 20 mg packaging label showing batch number, manufacturing date, package before date, and NDC number 23155-887-18. The label indicates storage instructions to keep tablets in tight containers at controlled room temperature between 20°C to 25°C (68°F to 77°F), with permitted excursions from 15°C to 30°C (59°F to 86°F). The label states an approximate quantity of 10 kg or about 121,000 tablets and notes the product is Rx only. Manufactured by Avet Pharmaceuticals Labs Inc., East Brunswick, NJ.*

FDA Label Image

40mg-90 (40mg 90)

Label for Lurasidone Hydrochloride Tablets 40 mg, film-coated oral tablets. The label indicates 90 tablets per container, Rx only, distributed by Avet Pharma. It includes pharmacist instructions about dispensing the medication guide, storage instructions to keep tablets in a tightly closed container at controlled room temperature away from light, and warnings to keep out of reach of children.*

FDA Label Image

40mg (40mg)

Label for Lurasidone Hydrochloride Tablets 40 mg featuring batch number, manufacturing date, package before date, and NDC number 23155-888-18. It states the quantity as approx. 60,500 tablets or 10 kg, with storage instructions to keep in tight containers at controlled room temperature. The label notes the product is Rx only and manufactured by Avet Pharmaceuticals Labs Inc., East Brunswick, NJ.*

FDA Label Image

60mg-90s (60mg 90)

Label for Lurasidone Hydrochloride Tablets 60 mg film-coated tablets by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label states the quantity of 90 tablets and includes dispensing instructions for pharmacists. It features a barcode, storage instructions, and a dose strength highlighted in a yellow box.*

FDA Label Image

60mg (60mg)

Lurasidone Hydrochloride Tablets 60 mg label showing batch number placeholder, manufacturing and packaging dates placeholders, NDC number 23155-889-18, quantity of 10 kg with approximately 40,000 tablets, and Rx only designation. Storage instructions specify preservation in tight containers at controlled room temperature. Manufactured by Avet Pharmaceuticals Labs Inc., East Brunswick, NJ.*

FDA Label Image

80mg-90 (80mg 90)

Lurasidone Hydrochloride Tablets 80 mg film-coated tablets packaging label. The container holds 90 tablets for oral use, labeled for prescription use only. The label includes dosage instructions, storage conditions, a barcode, and is branded with Avet Pharma and Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.*

FDA Label Image

80mg (80mg)

A label for Lurasidone Hydrochloride Tablets 80 mg, indicating a batch number, manufacturing date, and package before date in placeholder format. The quantity is approximately 10 kilograms or 30,000 tablets, with NDC number 23155-890-18. Storage instructions specify preserving in tight containers at 20° to 25°C (68° to 77°F) with permitted excursions between 15° to 30°C (59° to 86°F). The product is Rx only and manufactured by Avet Pharmaceuticals Labs Inc., East Brunswick, NJ.*

FDA Label Image

Avetlogo-mg (Avetlogo mg)

FDA Label Image

Avet-logo (Avet Logo)

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of Lurasidone Hydrochloride displaying the molecular arrangement of atoms, including several rings and functional groups characteristic of its compound.*

FDA Label Image

Figure-1 (Figure 1)

A forest plot illustrating the impact of various interacting drugs on the pharmacokinetics of Lurasidone Hydrochloride, showing fold changes and 90% confidence intervals for Cmax and AUC values. Interacting drugs include strong CYP3A4 inhibitors (Ketoconazole 400 mg/day), moderate CYP3A4 inhibitors (Diltiazem 240 mg/day), and strong CYP3A4 inducers (Rifampin 600 mg/day), as well as Lithium 600 mg BID. The x-axis represents change relative to lurasidone alone, ranging from -4 to 4.*

FDA Label Image

Figure-2 (Figure 2)

A forest plot chart illustrating pharmacokinetic (PK) changes of various interacting drugs relative to the interactive drug alone. The chart shows fold changes with 90% confidence intervals for drugs including P-gp substrates (Digoxin 0.25 mg SD), CYP3A4 substrates (Midazolam 5 mg SD), oral contraceptives (Ethinyl Estradiol, Norelgestromin), and Lithium 600 mg BID. The x-axis represents change relative to interactive drug alone, ranging from -1.0 to 1.0.*

FDA Label Image

Figure-3 (Figure 3)

A pharmacokinetic chart depicting fold change and 90% confidence intervals for Lurasidone Hydrochloride in populations with renal and hepatic impairment, along with gender and race comparisons. The x-axis shows change relative to reference, with markers for Cmax and AUC values under different conditions and population descriptions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.